Group B streptococcus

[1]  P. Cieslak,et al.  Capsule switching of Neisseria meningitidis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[2]  A. Schuchat,et al.  Adult Group B Streptococcal Disease , 1996, Annals of Internal Medicine.

[3]  A. Schuchat,et al.  Prevention of perinatal group B streptococcal disease : a public health perspective , 1996 .

[4]  R. Facklam,et al.  Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci , 1996, Journal of clinical microbiology.

[5]  A. Schuchat,et al.  Invasive group B streptococcal disease: the emergence of serotype V. , 1996, The Journal of infectious diseases.

[6]  J. E. Bennett,et al.  Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases , 2014 .

[7]  D. Stephens,et al.  Sporadic Meningococcal Disease in Adults: Results of a 5-Year Population-Based Study , 1995, Annals of Internal Medicine.

[8]  L. Harrison,et al.  Relapsing Invasive Group B Streptococcal Infection in Adults , 1995, Annals of Internal Medicine.

[9]  A. Schuchat,et al.  Risk Factors for Group B Streptococcal Disease in Adults , 1995, Annals of Internal Medicine.

[10]  M. Cetron,et al.  The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta. , 1995, The New England journal of medicine.

[11]  A. Schuchat,et al.  Should college students be vaccinated against meningococcal disease? A cost-benefit analysis. , 1995, American journal of public health.

[12]  M. Farley.  Group B Streptococcal Infection in Older Patients , 1995 .

[13]  M. Reeves,et al.  Epidemic-associated Neisseria meningitidis detected by multilocus enzyme electrophoresis. , 1995, Emerging infectious diseases.

[14]  A. Schuchat,et al.  Serogroup C meningococcal outbreaks in the United States. An emerging threat. , 1995, JAMA.

[15]  A. Schuchat,et al.  Multistate case-control study of maternal risk factors for neonatal group B streptococcal disease. The Active Surveillance Study Group. , 1994, The Pediatric infectious disease journal.

[16]  F. Tenover,et al.  Prevalence of Neisseria meningitidis relatively resistant to penicillin in the United States, 1991. Meningococcal Disease Study Group. , 1994, The Journal of infectious diseases.

[17]  A. Schuchat,et al.  Comparison of prevention strategies for neonatal group B streptococcal infection: A population‐based economic analysis , 1993, JAMA.

[18]  A. Schuchat,et al.  A population-based assessment of invasive disease due to group B Streptococcus in nonpregnant adults. , 1993, The New England journal of medicine.

[19]  E. Zell,et al.  Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era. , 1993, JAMA.

[20]  C. Broome,et al.  American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn: Guidelines for prevention of group B streptococcal (GBS) infection by chemoprophylaxis. , 1992, Pediatrics.

[21]  C. Broome,et al.  Invasive Haemophilus influenzae disease: a population-based evaluation of the role of capsular polysaccharide serotype. Haemophilus Influenzae Study Group. , 1992, The Journal of infectious diseases.

[22]  B. Plikaytis,et al.  Efficacy of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in US children aged 18-59 months , 1991, The Lancet.

[23]  R. Pinner,et al.  Meningococcal Disease in the United States—1986 , 1991 .

[24]  A. Schuchat,et al.  Use of surveillance for invasive pneumococcal disease to estimate the size of the immunosuppressed HIV-infected population. , 1991, JAMA.

[25]  A. Hightower,et al.  Bacterial meningitis in the United States, 1986: report of a multistate surveillance study. The Bacterial Meningitis Study Group. , 1990, The Journal of infectious diseases.

[26]  L. Harrison,et al.  Day care characteristics associated with Haemophilus influenzae disease. Haemophilus influenzae Study Group. , 1990, American journal of public health.

[27]  L. Harrison,et al.  Haemophilus influenzae Type b Polysaccharide Vaccine: An Efficacy Study , 1989, Pediatrics.

[28]  L. Harrison,et al.  A day care-based study of the efficacy of Haemophilus b polysaccharide vaccine. , 1988, JAMA.

[29]  K. Boyer.  Maternal screening in prevention of neonatal infections: current status and rationale for group B streptococcal screening. , 1988, The Journal of hospital infection.

[30]  K. Boyer,et al.  Prevention of early‐onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis , 1986, The New England journal of medicine.

[31]  M. Parker.  Basic Concepts of Streptocoçci and Streptococcal Diseases , 1983 .